PharmaMar and Jazz Pharmaceuticals have received FDA Priority Review of a NDA for lurbinectedin in relapsed...
Up To Date
Latest News
Using a combination of approved diabetes drugs, a Swiss-US research team was able to support the regeneration...
Researchers report that JAK inhibitors – a class of approved anti-inflammatory drugs – prevented bone loss in...
Mereo BioPharma has entered into a $5m convertible equity financing with Novartis and a $28m securities...
French Stilla Technologies SA raised €20m in a Series B funding to boost digital PCR-based genetic testing.
Targeted genome editing using the CRISPR-Cas9 system is easy to use but far from being perfect. Computer...